SmithKline
This article was originally published in The Rose Sheet
Executive Summary
Aquafresh 9% sales increase helps offset poor performances in SmithKline Beecham's other oral care brands in the third quarter, the company says Oct. 31. Worldwide oral care sales were up 2% to $244 mil. for the quarter and OTC drug sales remained unchanged at $489 mil., due in part to generic competition in smoking cessation products, SB reports on same-day conference call. Consolidated sales rose 6% to $3.25 bil. and income was up 21% to $589 mil., excluding a $57 mil. charge related to SB's restructuring program from proposed Glaxo Wellcome merger